Calmare Therapeutics to Present at the LD Micro "Main Event" Microcap Growth Conference
December 3, 2014

Fairfield, CT. - (December 3, 2014) - Calmare Therapeutics Incorporated, (CTTC) (CTI), the pain mitigation company, will present at the 7th Annual LD Micro "Main Event" Micro-Cap Growth Conference on Thursday, December 4 at 7:30 AM PT/10:30 AM EST. The conference will be held at the Luxe Sunset Bel Air Hotel, in Los Angeles, California.

Calmare Therapeutics President & CEO Conrad Mir will present. He is slated to provide an update on the Company's business development and the ongoing plan to maximize their signature technology, Calmare Pain Mitigation Therapy™. Mr. Mir will be available for one-on-one meetings during the conference.

"We are honored to have Calmare Therapeutics present at the Main Event this year," said LD Micro Founder Chris Lahiji.

About LD MICRO

LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Invitational. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit www.ldmicro.com.

About the Company

Calmare Therapeutics Inc., the pain mitigation company, develops and commercializes innovative wound and pain management products and technologies. CTI holds the 510k clearance on its flagship product, the non-invasive Calmare® Pain Therapy Device, which grants it an exclusive right to sell, market, research and develop the medical device. The Company is the exclusive licensed global distributor of Calmare.

Forward-Looking Statement

Certain statements contained in this press release are forward-looking statements that involve risks and uncertainties. The statements contained herein that are not purely historical are forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations and statements of future economic performance. Forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results in future periods to differ materially from what is currently anticipated. Factors that could cause or contribute to such differences include those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission. The Company cannot guarantee its future results, levels of activity, performance or achievements.

Direct inquiries to
Janet Vasquez
JV Public Relations
Email: This email address is protected. Javascript must be enabled to view it.
Tel: 212.645.5498